Document is current
Any future updates will be listed below
-
Authors
Fuster-RuizdeApodaca, María José
White, Trenton M.
Prats-Silvestre, Carlos
Holgado-Tello, Francisco P.
Lazarus, Jeffrey V.
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI20/01654)
- License Information
-
More Information
Article History
Received: 19 December 2024
Accepted: 25 July 2025
First Online: 5 August 2025
Declarations
:
: All study participants provided written informed consent. Ethical approval was obtained from the CeIM of the Hospital Clínic in Barcelona for the Delphi process. The Ethics Committee of the Instituto de Salud Carlos III (ISCIII) approved procedures for the CoRIS cohort study on 15-01-2020 (Nº: CEI PI 94_2019-v2).
: Digital informed consent was obtained for each person who participated in this study.
: MJF-R is a member of the Spanish Interdisciplinary AIDS Society (SEISIDA) Executive Board. SEISIDA has received grants from Gilead, Janssen, MSD and ViiV, outside of the submitted work. MJF-R has provided consultancy services to Gilead, Janssen, MSD, ViiV and Theratechnologies, and has received payments for lectures or educational presentations from Gilead, Janssen, MSD and ViiV, outside of the submitted work. JVL reports grants and speaker fees from Gilead Sciences and MSD and speaker fees from AbbVie, Genft, Intercept and ViiV, outside of the submitted work, and an institutional grant to ISGlobal from Gilead Sciences for other work packages of the comprehensive study of which the present research is a part. All other authors report no conflicts of interest.
